EFCYVEP

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Dec 2025 filing date already counts against anyone who files later.

Record

Serial number

99540986

Mark type

Stylized text

Filed

10 Dec 2025

Published for opposition

24 Feb 2026

Attorney of record

John R. Rudolph

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Owner

• Eli Lilly and Company, Indianapolis, IN, US
• Eli Lilly and Company, Indianapolis, IN, US

Prosecution history

• 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Feb 2026 — PUBLISHED FOR OPPOSITION
• 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 30 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 26 Jan 2026 — ASSIGNED TO EXAMINER
• 10 Dec 2025 — APPLICATION FILING RECEIPT MAILED
• 10 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 10 Dec 2025 — NEW APPLICATION ENTERED